BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25189625)

  • 1. Ganitumab for the treatment of small-cell lung cancer.
    Martínez P; Sales Fidalgo PA; Felip E
    Expert Opin Investig Drugs; 2014 Oct; 23(10):1423-32. PubMed ID: 25189625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of antibody therapeutics for small cell lung cancer.
    Zhan J; Han Q; Wang K
    Expert Opin Investig Drugs; 2013 Feb; 22(2):235-44. PubMed ID: 23176362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New targeted therapies and small-cell lung cancer.
    Rossi A; Maione P; Palazzolo G; Sacco PC; Ferrara ML; Falanga M; Gridelli C
    Clin Lung Cancer; 2008 Sep; 9(5):271-9. PubMed ID: 18824449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical treatment of small cell lung cancer: state of the art and new development.
    Sgambato A; Casaluce F; Maione P; Rossi A; Sacco PC; Panzone F; Ciardiello F; Gridelli C
    Expert Opin Pharmacother; 2013 Oct; 14(15):2019-31. PubMed ID: 23901936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive-stage small-cell lung cancer: evolution of systemic therapy and future directions.
    Allen J; Jahanzeb M
    Clin Lung Cancer; 2008 Sep; 9(5):262-70. PubMed ID: 18953759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging drugs for small-cell lung cancer.
    Metro G; Cappuzzo F
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):591-606. PubMed ID: 19694501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer.
    Cao H; Dong W; Shen H; Xu J; Zhu L; Liu Q; Du J
    PLoS One; 2015; 10(8):e0135844. PubMed ID: 26287334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in antibody therapeutics targeting small-cell lung cancer.
    Lu H; Jiang Z
    Adv Clin Exp Med; 2018 Sep; 27(9):1317-1323. PubMed ID: 29790694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential role of insulin-like growth factor receptor inhibitors in the treatment of advanced non-small cell lung cancer.
    Gridelli C; Rossi A; Bareschino MA; Schettino C; Sacco PC; Maione P
    Expert Opin Investig Drugs; 2010 May; 19(5):631-9. PubMed ID: 20367288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on new drugs in small cell lung cancer.
    Horn L; Castellanos EL; Johnson DH
    Expert Opin Investig Drugs; 2011 Apr; 20(4):441-5. PubMed ID: 21395484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in pharmacotherapy of small cell lung cancer.
    Kalemkerian GP
    Expert Opin Pharmacother; 2014 Nov; 15(16):2385-96. PubMed ID: 25255939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancer.
    Chang MH; Lee J; Han J; Park YH; Ahn JS; Park K; Ahn MJ
    APMIS; 2009 Dec; 117(12):861-9. PubMed ID: 20078550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt.
    Yeh J; Litz J; Hauck P; Ludwig DL; Krystal GW
    Lung Cancer; 2008 May; 60(2):166-74. PubMed ID: 18006183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapies for small cell lung cancer: Where do we stand?
    Arcaro A
    Crit Rev Oncol Hematol; 2015 Aug; 95(2):154-64. PubMed ID: 25800975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of extensive-stage small cell lung carcinoma: current status and future prospects.
    Demedts IK; Vermaelen KY; van Meerbeeck JP
    Eur Respir J; 2010 Jan; 35(1):202-15. PubMed ID: 20044461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of surgical resection in treating small cell lung cancer].
    Ye B; Zhao SH; Liu XY
    Ai Zheng; 2007 Jul; 26(7):795-7. PubMed ID: 17626763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of ganitumab (AMG 479), alone and in combination with rapamycin, in Ewing's and osteogenic sarcoma models.
    Beltran PJ; Chung YA; Moody G; Mitchell P; Cajulis E; Vonderfecht S; Kendall R; Radinsky R; Calzone FJ
    J Pharmacol Exp Ther; 2011 Jun; 337(3):644-54. PubMed ID: 21385891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs for small cell lung cancer: a focused review on immune checkpoint inhibitors.
    Reddy HG; Qin A; Kalemkerian GP
    Expert Opin Emerg Drugs; 2020 Sep; 25(3):353-366. PubMed ID: 32683991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for IGF-1R-targeted therapies in small-cell lung cancer?
    Gately K; Collins I; Forde L; Al-Alao B; Young V; Gerg M; Feuerhake F; O'Byrne K
    Clin Lung Cancer; 2011 Jan; 12(1):38-42. PubMed ID: 21273178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized Therapy of Small Cell Lung Cancer.
    Schneider BJ; Kalemkerian GP
    Adv Exp Med Biol; 2016; 890():149-74. PubMed ID: 26703804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.